Cargando…

The autophagic marker p62 highlights Alzheimer type II astrocytes in metabolic/hepatic encephalopathy

Metabolic/hepatic encephalopathy is neuropathologically characterized by the presence of Alzheimer type II astrocytes (AA II) with large and clear nuclear morphology. To date, there is no good immunohistochemical marker to better identify these cells. Here, we assessed cases of hepatic encephalopath...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelpi, Ellen, Rahimi, Jasmin, Klotz, Sigrid, Schmid, Susanne, Ricken, Gerda, Forcen‐Vega, Sara, Budka, Herbert, Kovacs, Gabor G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496304/
https://www.ncbi.nlm.nih.gov/pubmed/32483828
http://dx.doi.org/10.1111/neup.12660
_version_ 1783583067809513472
author Gelpi, Ellen
Rahimi, Jasmin
Klotz, Sigrid
Schmid, Susanne
Ricken, Gerda
Forcen‐Vega, Sara
Budka, Herbert
Kovacs, Gabor G.
author_facet Gelpi, Ellen
Rahimi, Jasmin
Klotz, Sigrid
Schmid, Susanne
Ricken, Gerda
Forcen‐Vega, Sara
Budka, Herbert
Kovacs, Gabor G.
author_sort Gelpi, Ellen
collection PubMed
description Metabolic/hepatic encephalopathy is neuropathologically characterized by the presence of Alzheimer type II astrocytes (AA II) with large and clear nuclear morphology. To date, there is no good immunohistochemical marker to better identify these cells. Here, we assessed cases of hepatic encephalopathy of different etiologies by immunohistochemistry using an anti‐p62 antibody. We observed peripheral or diffuse nuclear staining of variable intensity in AA II in all cases but not in normal controls or reactive astrocytes. We conclude that p62 is a useful immunohistochemical marker for the identification of AA II and may be helpful for the neuropathological diagnosis of metabolic/hepatic encephalopathy in difficult or equivocal cases.
format Online
Article
Text
id pubmed-7496304
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons Australia, Ltd
record_format MEDLINE/PubMed
spelling pubmed-74963042020-09-25 The autophagic marker p62 highlights Alzheimer type II astrocytes in metabolic/hepatic encephalopathy Gelpi, Ellen Rahimi, Jasmin Klotz, Sigrid Schmid, Susanne Ricken, Gerda Forcen‐Vega, Sara Budka, Herbert Kovacs, Gabor G. Neuropathology Original Articles Metabolic/hepatic encephalopathy is neuropathologically characterized by the presence of Alzheimer type II astrocytes (AA II) with large and clear nuclear morphology. To date, there is no good immunohistochemical marker to better identify these cells. Here, we assessed cases of hepatic encephalopathy of different etiologies by immunohistochemistry using an anti‐p62 antibody. We observed peripheral or diffuse nuclear staining of variable intensity in AA II in all cases but not in normal controls or reactive astrocytes. We conclude that p62 is a useful immunohistochemical marker for the identification of AA II and may be helpful for the neuropathological diagnosis of metabolic/hepatic encephalopathy in difficult or equivocal cases. John Wiley & Sons Australia, Ltd 2020-06-02 2020-08 /pmc/articles/PMC7496304/ /pubmed/32483828 http://dx.doi.org/10.1111/neup.12660 Text en © 2020 The Authors. Neuropathology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Neuropathology. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Gelpi, Ellen
Rahimi, Jasmin
Klotz, Sigrid
Schmid, Susanne
Ricken, Gerda
Forcen‐Vega, Sara
Budka, Herbert
Kovacs, Gabor G.
The autophagic marker p62 highlights Alzheimer type II astrocytes in metabolic/hepatic encephalopathy
title The autophagic marker p62 highlights Alzheimer type II astrocytes in metabolic/hepatic encephalopathy
title_full The autophagic marker p62 highlights Alzheimer type II astrocytes in metabolic/hepatic encephalopathy
title_fullStr The autophagic marker p62 highlights Alzheimer type II astrocytes in metabolic/hepatic encephalopathy
title_full_unstemmed The autophagic marker p62 highlights Alzheimer type II astrocytes in metabolic/hepatic encephalopathy
title_short The autophagic marker p62 highlights Alzheimer type II astrocytes in metabolic/hepatic encephalopathy
title_sort autophagic marker p62 highlights alzheimer type ii astrocytes in metabolic/hepatic encephalopathy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496304/
https://www.ncbi.nlm.nih.gov/pubmed/32483828
http://dx.doi.org/10.1111/neup.12660
work_keys_str_mv AT gelpiellen theautophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT rahimijasmin theautophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT klotzsigrid theautophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT schmidsusanne theautophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT rickengerda theautophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT forcenvegasara theautophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT budkaherbert theautophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT kovacsgaborg theautophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT gelpiellen autophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT rahimijasmin autophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT klotzsigrid autophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT schmidsusanne autophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT rickengerda autophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT forcenvegasara autophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT budkaherbert autophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy
AT kovacsgaborg autophagicmarkerp62highlightsalzheimertypeiiastrocytesinmetabolichepaticencephalopathy